Nisa Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Nisa Investment Advisors, LLC

$15.2 Billion
Q1 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 490,983 shares of BMY stock, worth $20.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

490,983

Previous 559,661 12.27%

Holding current value

$20.4 Million

Previous $28.7 Million 7.28%

% of portfolio

0.18%

Previous 0.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $3.3 Million - $3.74 Million	-68,678 Reduced 12.27%	490,983 $26.6 Million
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $2.26 Million - $2.69 Million	-46,526 Reduced 7.68%	559,661 $28.7 Million
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $2.87 Million - $3.21 Million	-49,567 Reduced 7.56%	606,187 $35.2 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $484,004 - $537,411	7,597 Added 1.17%	655,754 $41.9 Million
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $1.47 Million - $1.67 Million	-22,398 Reduced 3.34%	648,157 $44.9 Million

Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $1.45 Million - $1.71 Million	-21,146 Reduced 3.06%	670,555 $48.2 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $1,151 - $680,879	8,861 Added 1.3%	691,701 $49.3 Million
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $2.08 Million - $2.29 Million	28,622 Added 4.37%	682,840 $52.6 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $15.1 Million - $18.1 Million	-245,346 Reduced 27.27%	654,218 $47.8 Million
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $11.9 Million - $13.9 Million	222,312 Added 32.83%	899,564 $58.4 Million
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $1.19 Million - $1.4 Million	20,156 Added 3.07%	677,252 $40.1 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $746,882 - $813,354	-12,064 Reduced 1.8%	657,096 $43.9 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $1.91 Million - $2.15 Million	32,150 Added 5.05%	669,160 $42.2 Million
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $1.18 Million - $1.34 Million	-20,441 Reduced 3.11%	637,010 $39.5 Million
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $2.64 Million - $2.92 Million	-45,930 Reduced 6.53%	657,451 $39.6 Million
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $4.19 Million - $4.9 Million	-76,397 Reduced 9.8%	703,381 $41.4 Million
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $5.4 Million - $7.85 Million	-116,347 Reduced 12.98%	779,778 $43.5 Million
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $14.8 Million - $19.3 Million	300,785 Added 50.52%	896,125 $57.5 Million
Q3 2019 Oct 17, 2019	SELL	$42.77 - $50.71 $166,546 - $197,464	-3,894 Reduced 0.65%	595,340 $30.2 Million
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $637,887 - $705,364	14,296 Added 2.44%	599,234 $27.2 Million
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $443,168 - $528,423	-9,822 Reduced 1.65%	584,938 $27.9 Million
Q4 2018 Jan 17, 2019	BUY	$48.76 - $63.23 $604,770 - $784,241	12,403 Added 2.13%	594,760 $30.9 Million
Q3 2018 Oct 16, 2018	BUY	$55.19 - $62.25 $137,588 - $155,189	2,493 Added 0.43%	582,357 $36.2 Million
Q2 2018 Jul 19, 2018	SELL	$50.53 - $62.98 $1.72 Million - $2.14 Million	-33,957 Reduced 5.53%	579,864 $32.1 Million
Q1 2018 Apr 10, 2018	BUY	$59.92 - $68.98 $345,318 - $397,531	5,763 Added 0.95%	613,821 $39.2 Million
Q4 2017 Jan 12, 2018	BUY	$59.94 - $65.35 $1.62 Million - $1.77 Million	27,053 Added 4.66%	608,058 $37.3 Million
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $32.1 Million - $37 Million	581,005	581,005 $37 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Bristol Myers Squibb CO Transaction History